IDEAYA Biosciences, Inc. (IDYA)
38.41
-0.20
(-0.52%)
USD |
NASDAQ |
Sep 18, 16:00
38.41
0.00 (0.00%)
After-Hours: 20:00
IDEAYA Biosciences Price : 38.41 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 38.88 | 39.24 | 38.15 | 38.41 | 2.493M |
| Sep 17, 2026 | 38.61 | 39.47 | 38.53 | 38.61 | 757774.0 |
| Sep 16, 2026 | 37.71 | 38.46 | 37.24 | 37.73 | 639913.0 |
| Sep 15, 2026 | 37.88 | 38.24 | 37.12 | 37.66 | 654233.0 |
| Sep 14, 2026 | 38.50 | 39.33 | 37.74 | 38.03 | 524744.0 |
| Sep 11, 2026 | 37.74 | 38.27 | 37.24 | 37.59 | 429248.0 |
| Sep 10, 2026 | 37.85 | 38.40 | 37.37 | 37.45 | 547791.0 |
| Sep 09, 2026 | 39.19 | 39.19 | 38.21 | 38.35 | 488551.0 |
| Sep 08, 2026 | 38.90 | 39.47 | 38.59 | 38.84 | 805961.0 |
| Sep 04, 2026 | 39.55 | 40.07 | 39.42 | 39.86 | 448008.0 |
| Sep 03, 2026 | 40.41 | 40.66 | 39.56 | 39.97 | 567895.0 |
| Sep 02, 2026 | 40.20 | 41.48 | 39.58 | 40.17 | 765286.0 |
| Sep 01, 2026 | 39.85 | 40.20 | 38.90 | 39.95 | 587802.0 |
| Aug 31, 2026 | 39.74 | 40.32 | 39.43 | 40.10 | 977808.0 |
| Aug 28, 2026 | 41.14 | 41.64 | 40.04 | 40.11 | 714066.0 |
| Aug 27, 2026 | 41.63 | 42.10 | 40.96 | 41.77 | 534405.0 |
| Aug 26, 2026 | 42.26 | 42.32 | 41.09 | 41.58 | 724900.0 |
| Aug 25, 2026 | 40.88 | 42.68 | 40.06 | 42.48 | 1.022M |
| Aug 24, 2026 | 39.73 | 40.46 | 39.12 | 40.04 | 786771.0 |
| Aug 21, 2026 | 39.34 | 40.56 | 39.31 | 39.67 | 860570.0 |
| Aug 20, 2026 | 38.24 | 39.28 | 37.89 | 39.11 | 1.634M |
| Aug 19, 2026 | 39.01 | 39.30 | 37.84 | 38.87 | 931924.0 |
| Aug 18, 2026 | 36.41 | 37.98 | 36.39 | 37.93 | 629485.0 |
| Aug 17, 2026 | 36.04 | 36.82 | 35.80 | 36.54 | 427842.0 |
| Aug 14, 2026 | 36.68 | 36.68 | 35.66 | 36.30 | 435255.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Xencor, Inc. | 24.72 |
| UroGen Pharma Ltd. | 43.25 |
| MeiraGTx Holdings Plc | 13.25 |
| ACADIA Pharmaceuticals, Inc. | 27.29 |
| Alnylam Pharmaceuticals, Inc. | 239.56 |
Price Related Metrics
| PS Ratio | 14.73 |
| Price to Book Value | 3.088 |
| Earnings Yield | -5.06% |
| Market Cap | 3.702B |